Document Detail

Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng (Panax quinquefolium).
MedLine Citation:
PMID:  11732754     Owner:  NLM     Status:  MEDLINE    
The activity of CVT-E002, an aqueous extract containing mainly oligosaccharides and polysaccharides from North American ginseng (Panax quinquefolium), as an immunobooster on murine spleen cells and peritoneal macrophages, was studied in-vitro. CVT-E002 stimulated the proliferation of normal mouse spleen cells, of which the major responding subpopulation was identified as B lymphocytes. CVT-E002 also activated peritoneal exudate macrophages leading to enhanced interleukin-1 (IL-1), interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-alpha) and nitric oxide (NO) production. In addition, CVT-E002 stimulated in-vivo immunoglobulin G (IgG) production in treated mice. These results identify some of the immunomodulating activities of CVT-E002 and suggest its use clinically for the modulation of immune responses.
M Wang; L J Guilbert; L Ling; J Li; Y Wu; S Xu; P Pang; J J Shan
Related Documents :
7718414 - Activation of murine macrophages by hydrogen peroxide.
234914 - Effect of corynebacterium acnes on interferon production in mouse peritoneal exudate ce...
20682314 - A distinct subset of podoplanin (gp38) expressing f4/80+ macrophages mediate phagocytos...
8801524 - Modulation of murine peritoneal macrophage functions by gastrin.
23071254 - Identification of axl as a downstream effector of tgf-β1 during langerhans cell differe...
16179034 - Have gastrointestinal nematodes outwitted the immune system?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of pharmacy and pharmacology     Volume:  53     ISSN:  0022-3573     ISO Abbreviation:  J. Pharm. Pharmacol.     Publication Date:  2001 Nov 
Date Detail:
Created Date:  2001-12-04     Completed Date:  2002-04-05     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0376363     Medline TA:  J Pharm Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1515-23     Citation Subset:  IM    
CV Technologies Inc, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adjuvants, Immunologic / pharmacology*
Cell Division / drug effects
Dose-Response Relationship, Drug
Immunity, Innate / drug effects
Immunoglobulin G / blood,  drug effects
Interleukin-1 / metabolism
Interleukin-6 / metabolism
Macrophages / drug effects,  metabolism
Mice, Inbred BALB C
Mice, Inbred C57BL
Nitric Oxide / metabolism
Panax / chemistry*
Plant Extracts / pharmacology*
Spleen / cytology,  drug effects
Tumor Necrosis Factor-alpha / metabolism
Reg. No./Substance:
0/Adjuvants, Immunologic; 0/Immunoglobulin G; 0/Interleukin-1; 0/Interleukin-6; 0/Plant Extracts; 0/Tumor Necrosis Factor-alpha; 10102-43-9/Nitric Oxide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Design, synthesis and biological testing of a novel series of anti-inflammatory drugs.
Next Document:  Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced tox...